Lisata Therapeutics, Inc. (LSTA) SEC filings
LSTA SEC filings moved a median of +0.80% by the close. LSTA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the LSTA overview →
61 measured LSTA SEC filing events.
Where these LSTA SEC filings landedvs 61 measured LSTA SEC filing reactions
| Middle 50% of LSTA SEC filing reactions | -2.00% to +3.30% |
|---|---|
| Median reaction (to close) | +0.80% |
| Measured reactions | 61 |
Point-in-time · zero look-ahead
Half of the 61 LSTA SEC filing events with a measured close landed between -2.00% and +3.30%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form ARS LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | -1.94% | -2.91% | |
| Form DEF 14A LISATA THERAPEUTICS, For: Nov 09 | SEC filing · Form DEF | -1.94% | -2.91% | |
| Form 8-K LISATA THERAPEUTICS, For: Oct 13 | SEC filing · Form 8-K | +0.00% | +1.91% | |
| Form PRE 14A LISATA THERAPEUTICS, For: Nov 09 | SEC filing · Form PRE | -0.82% | -1.64% | |
| Form D LISATA THERAPEUTICS, | SEC filing · Form D | +0.00% | -13.10% | |
| Form 8-K LISATA THERAPEUTICS, For: Sep 17 | SEC filing · Form 8-K | -34.20% | -30.40% | |
| Form 10-Q LISATA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | — | +0.95% | |
| Form 8-K LISATA THERAPEUTICS, For: Aug 03 | SEC filing · Form 8-K | +0.00% | +11.77% | |
| Form 8-K LISATA THERAPEUTICS, For: Jul 24 | SEC filing · Form 8-K | -5.64% | -18.14% | |
| Form 8-K LISATA THERAPEUTICS, For: Jul 16 | SEC filing · Form 8-K | +0.56% | -0.14% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 08 | SEC filing · Form 8-K | +0.87% | +0.58% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 01 | SEC filing · Form 8-K | +0.29% | +3.77% | |
| Form 8-K LISATA THERAPEUTICS, For: May 29 | SEC filing · Form 8-K | +0.29% | +3.77% | |
| Form 10-Q LISATA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.88% | |
| Form 8-K LISATA THERAPEUTICS, For: May 03 | SEC filing · Form 8-K | -0.31% | +4.04% | |
| Form 10-K/A LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +1.56% | +0.63% | |
| Form 8-K LISATA THERAPEUTICS, For: Apr 15 | SEC filing · Form 8-K | +2.27% | -9.89% | |
| Form 8-K LISATA THERAPEUTICS, For: Apr 02 | SEC filing · Form 8-K | +0.00% | -0.20% | |
| Form 10-K LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.40% | +0.40% | |
| Form 8-K LISATA THERAPEUTICS, For: Mar 06 | SEC filing · Form 8-K | +0.70% | +0.80% | |
| Form 8-K LISATA THERAPEUTICS, For: Feb 27 | SEC filing · Form 8-K | -0.94% | +3.30% | |
| Form 8-K LISATA THERAPEUTICS, For: Jan 27 | SEC filing · Form 8-K | -0.65% | +2.70% | |
| Form 8-K LISATA THERAPEUTICS, For: Jan 20 | SEC filing · Form 8-K | +0.00% | +1.00% | |
| Form S-8 LISATA THERAPEUTICS, | SEC filing · Form S-8 | +0.00% | -0.51% | |
| Form 10-Q LISATA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -0.94% | -3.29% | |
| Form 8-K LISATA THERAPEUTICS, For: Nov 06 | SEC filing · Form 8-K | -0.94% | -3.29% | |
| Form 8-K LISATA THERAPEUTICS, For: Oct 14 | SEC filing · Form 8-K | +0.85% | +3.40% | |
| Form 8-K LISATA THERAPEUTICS, For: Oct 08 | SEC filing · Form 8-K | +1.83% | +0.40% | |
| Form 10-Q LISATA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.26% | |
| Form 8-K LISATA THERAPEUTICS, For: Aug 07 | SEC filing · Form 8-K | +0.00% | -2.26% | |
| Form 8-K LISATA THERAPEUTICS, For: Jul 15 | SEC filing · Form 8-K | -2.32% | +4.25% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 26 | SEC filing · Form 8-K | +0.62% | +16.67% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 17 | SEC filing · Form 8-K | — | -0.41% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 10 | SEC filing · Form 8-K | -0.41% | +2.45% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 10 | SEC filing · Form 8-K | +0.00% | -5.02% | |
| Form 10-Q LISATA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -12.13% | |
| Form 8-K LISATA THERAPEUTICS, For: May 08 | SEC filing · Form 8-K | +0.00% | -12.13% | |
| Form DEF 14A LISATA THERAPEUTICS, For: Apr 25 | SEC filing · Form DEF | — | +3.69% | |
| Form DEFA14A LISATA THERAPEUTICS, | SEC filing · Form DEFA14A | — | +3.69% | |
| Form 10-K LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.03% | |
| Form 8-K LISATA THERAPEUTICS, For: Feb 27 | SEC filing · Form 8-K | +0.00% | +3.03% | |
| Form 8-K LISATA THERAPEUTICS, For: Jan 22 | SEC filing · Form 8-K | +1.25% | +11.67% | |
| Form 8-K LISATA THERAPEUTICS, For: Dec 03 | SEC filing · Form 8-K | +5.92% | +1.11% | |
| Form 10-Q LISATA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.79% | |
| Form 8-K LISATA THERAPEUTICS, For: Nov 12 | SEC filing · Form 8-K | +0.00% | -2.79% | |
| Form 10-Q LISATA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.00% | |
| Form 8-K LISATA THERAPEUTICS, For: Aug 12 | SEC filing · Form 8-K | +0.00% | -2.00% | |
| Form S-8 LISATA THERAPEUTICS, | SEC filing · Form S-8 | -0.53% | -1.33% | |
| Form 8-K LISATA THERAPEUTICS, For: Jun 27 | SEC filing · Form 8-K | — | +0.87% | |
| Form EFFECT LISATA THERAPEUTICS, | SEC filing · Form EFFECT | -0.17% | +1.55% | |
| Form 10-Q LISATA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -0.17% | +1.55% | |
| Form 8-K LISATA THERAPEUTICS, For: May 09 | SEC filing · Form 8-K | -0.17% | +1.55% | |
| Form S-3 LISATA THERAPEUTICS, | SEC filing · Form S-3 | — | +4.64% | |
| Form DEF 14A LISATA THERAPEUTICS, For: Apr 29 | SEC filing · Form DEF | +0.00% | +0.00% | |
| Form DEFA14A LISATA THERAPEUTICS, | SEC filing · Form DEFA14A | +0.00% | +0.00% | |
| Form 8-K LISATA THERAPEUTICS, For: Apr 15 | SEC filing · Form 8-K | — | +2.15% | |
| Form ARS LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | +0.00% | -0.35% | |
| Form 10-K LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +9.18% | +5.44% | |
| Form 8-K LISATA THERAPEUTICS, For: Feb 29 | SEC filing · Form 8-K | +9.18% | +5.44% | |
| Form 10-Q LISATA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | — | +7.76% | |
| Form 8-K LISATA THERAPEUTICS, For: Nov 02 | SEC filing · Form 8-K | — | +7.76% |
Keep exploring
More LSTA: earnings → · analyst actions → · LSTA overview →